Pura Vida Investments, LLC Arvinas, Inc. Transaction History

Pura Vida Investments, LLC

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2021 Nov 15, 2021	SELL	$73.2 - $107.87 $2.31 Million - $3.4 Million	-31,543 Closed	0 $0
Q2 2021 Aug 16, 2021	SELL	$60.45 - $84.26 $28,653 - $39,939	-474 Reduced 1.48%	31,543 $2.43 Million
Q1 2021 May 12, 2021	BUY	$58.19 - $91.37 $117,369 - $184,293	2,017 Added 6.72%	32,017 $2.12 Million
Q4 2020 Feb 16, 2021	BUY	$20.19 - $84.93 $605,700 - $2.55 Million	30,000 New	30,000 $2.55 Million
Q4 2019 Feb 14, 2020	SELL	$15.39 - $44.38 $988,176 - $2.85 Million	-64,209 Closed	0 $0
Q3 2019 Nov 14, 2019	BUY	$21.55 - $27.61 $1.38 Million - $1.77 Million	64,209 New	64,209 $1.38 Million
Q4 2018 Feb 14, 2019	SELL	$11.19 - $18.56 $839,250 - $1.39 Million	-75,000 Closed	0 $0
Q3 2018 Nov 14, 2018	BUY	$16.05 - $16.87 $1.2 Million - $1.27 Million	75,000 New	75,000 $1.27 Million

229

68.4M

226K

285K

Ticker ARVN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 53,205,300
Market Cap $1.02B
Description
Arvinas, Inc., a clinical-stage biopharmaceutical company, engages in the discovery, development, and commercialization of therapies to degrade disease-causing proteins. Its lead product candidates include Bavdegalutamide, a proteolysis targeting chimera (PROTAC) protein degrader that is in phase I clinical trial targeting the androgen receptor ...

Get notified when there are updates to the investment portfolio of Pura Vida Investments, LLC, based on Form 13F filings with the SEC.

Stay updated on Pura Vida Investments, LLC with notifications on news.